HMG-CoA reductase inhibitor tablets prescribed for primary hypercholesterolemia and mixed dyslipidemia. Fabricated by pharmaceutical companies, traded in B2B marketplaces to clinics, lipid management programs, and retail outlets for use by internists and cardiologists.